Rare diseases
Investigational molecules
Locations
A Study to Evaluate the Safety and Effectiveness of Ritlecitinib Tosilate in Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyA Study of Mevrometostat and Enzalutamide for Men with Metastatic Castration-Sensitive Prostate Cancer Who Have Not Received Hormonal Therapy or Chemotherapy
GermanyStudy of xaluritamig compared to cabazitaxel or androgen receptor therapy for patients with metastatic castration-resistant prostate cancer
GermanyA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
GermanyStudy of Cromolyn Inhalation Treatment for Patients with Mild to Moderate Amyotrophic Lateral Sclerosis (ALS)
GermanyStudy of luxdegalutamide and abiraterone combination in adult men with metastatic hormone-sensitive prostate cancer
GermanyStudy of tarlatamab with durvalumab, carboplatin and etoposide versus standard treatment in patients with previously untreated extensive stage small cell lung cancer
GermanyStudy of ruxolitinib cream for treating hidradenitis suppurativa in adult patients
GermanyComparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies
GermanyStudy comparing empasiprubart versus intravenous immunoglobulin for treating adults with multifocal motor neuropathy
GermanyStudy Comparing BMS-986365 with Other Treatments for Patients with Metastatic Castration-resistant Prostate Cancer
GermanyStudy Comparing Belantamab Mafodotin with Lenalidomide and Dexamethasone to Daratumumab with Lenalidomide and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
